Cyclica (acquired by Recursion, Nasdaq: RXRX) Email Format
Biotechnology ResearchCanada51-200 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.